Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice
https://doi.org/10.29413/ABS.2018-3.2.4
Abstract
The aim of the study was to investigate the effectiveness of tiotropium bromide in patients with severe persistent asthma under conditions of real clinical practice. The study group included 20 outpatients who, despite the maximum volumes of basic therapy, maintained an uncontrolled course of the disease. In addition to previous therapy, patients were given tiotropium bromide 5 mg per day. The study lasted five months. During this period, clinical symptoms, the presence of exacerbations of asthma, spirometry parameters, the level of disease control according to the questionnaire Asthma Control Questionnaire™ (ACQ-5) and the quality of life of patients were monthly evaluated. It has been found that the inclusion of tiotropium bromide in the treatment regimen causes a significant improvement in asthma control, the ACQ-5 index decreased by 48 %. There was also a significant dynamics of postbronchodilation FEV1 and quality of life indicators. None of the patients had a worsening of the disease during the observation period. However, in order to achieve a therapeutic effect, systematic tiotropium bromide therapy was required for at least three months. The results obtained confirmed the positive effect of tiotropium bromide on the control of asthma and the quality of life.
About the Authors
A. F. Ivanov
Irkutsk State Medical Academy of Postgraduate Education -Branch Campus of the Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
B. A. Chernyak
Irkutsk State Medical Academy of Postgraduate Education -Branch Campus of the Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
References
1. Хельсинская декларация Всемирной медицинской ассоциации. Этические принципы проведения медицинских исследований с участием человека в качестве субъекта // Клиническая информатика и телемедицина. - 2014. - Т. 10, № 11. - C. 119-122
2. Черняк Б.А., Трофименко И.Н. Влияние терапии тиотропием на бронхиальную гиперреактивность и клинико-функциональные показатели у больных хронической обструктивной болезнью легких // Пульмонология. - 2012. - № 2. - C. 46-51
3. Gosens R, Bos IS, Zaagsma J, Meurs H. (2005). Protective effects of tiotropium bromidein the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med, 171, 1096-1102.
4. Jones PW, Quirk FH, Baveystock SM. (1991). The St George’s Respiratory Questionnaire. Respir Med, 85 (Suppl B), 25-31.
5. Juniper EF, Svennson K. (2005). Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med, 99 (5), 533-538
6. Kang JY, Rhee CK, Kim JS. (2012). Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Ann Allergy Asthma Immunol, 109, 29-35.
7. Kerstjens HAM, Disse B, Shroder-Babo W. (2011). Tiotropium improves lung function in patients with uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol, 128 (2), 308-314.
8. Kerstjens HAM, Engle M, Dahl R. (2012). Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med, 367, 1257-1259.
9. Miller MR, Crapo R, Hamkinson J, Brusasko V, Burgos F, Casaburi R, Coates A, Enright P. (2005). General consideration of lung function testing. Eur Resp Journal, 26 (1), 153-161.
10. Pera T, Ziudhof A, Valadas J, Smit M, Shoemaker RG, Gosens R, Maarsingh H, Zaagsma J, Meurs H. (2011). Tiotropium inhibits pulmonary inflammation and remodeling in a guinea pig model. Eur Respir J, 38 (4), 789-796.
11. Peters SP, Kunselman SJ, Icitovic N. (2010). Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med, 363 (18), 17151726.
12. Tashkin DP, Celli B, Senn S. (2008). A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med, 359 (15), 1543-1544.
13. Ullah MU, Khan MB, Liaqat J, Iftikhar R, Kamran SM, Khalil A. (2013). Role of tiotropium as step up therapy for asthma. Journal of Rawalpindi Medical College, 17 (2), 169-171.
14. Vogelmeier C, Hederer B, Glaab T. (2011). Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med, 364, 1093-1103.
Review
For citations:
Ivanov A.F., Chernyak B.A. Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice. Acta Biomedica Scientifica. 2018;3(2):25-29. (In Russ.) https://doi.org/10.29413/ABS.2018-3.2.4
Views:
722
Email this article 
